{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}],"title":"Unknown cause of death"},{"measurements":[{"groupId":"OG000","value":"31"}],"title":"Alive"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"32"}],"units":"Participants"}],"description":"The contributing cause of death for patients with high risk endometrial cancer","groups":[{"description":"Vaginal cuff brachytherapy followed by Carboplatin (AUC 6) on day 1and Paclitaxel 80 mg/m2 IV over 1 hour days 1, 8, and 15 X 3 total cycles\n\nVaginal Cuff Brachytherapy: Within 12 weeks of surgery. Either LDR or HDR brachytherapy will be permitted\n\nCarboplatin: Carboplatin IV on day 1 of a 21 day cycle for 3 cycles\n\nPaclitaxel: Paclitaxel IV on days 1,8 and 15 of a 21 day cycle for 3 cycles","id":"OG000","title":"Vaginal Cuff Brachytherapy + Chemotherapy"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Number of patients who died following protocol treatment","reportingStatus":"POSTED","timeFrame":"up to 2 years","title":"Contributing Cause of Death","type":"SECONDARY","unitOfMeasure":"Participants"}